Compare Akbar Indo Makmur Stimec Tbk (AIMS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Akbar Indo Makmur Stimec Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp390 (market cap 84.48B, 127.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Akbar Indo Makmur Stimec Tbk is more actively traded (127.3K versus 50.3K). Which is the better fit depends on your goals.
| AIMS | OBAT | |
|---|---|---|
Market Cap | 84.48B | 164.65B |
Volume | 127.3K | 50.3K |
Lot | 1.27K | 503 |
Turnover | 49.8M | 12.13M |
Average Price | 391.2 | 241.18 |
Value | 49.8M | 12.13M |
Indicative Equilibrium Price | 384 | 238 |
Indicative Equilibrium Volume | 200 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Akbar Indo Makmur Stimec Tbk
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Read more on AIMS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
